Ratings Summary for EFFEXOR
Overall Patient opinion of EFFEXOR: 3.0 (somewhat satisfied)
(based on 926 reviews ) (updated May 6, 2025)Ratings by Age Group for EFFEXOR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 9 | 3.3 |
| Age 18 to 24 | 121 | 3.0 |
| Age 25 to 34 | 271 | 3.0 |
| Age 35 to 44 | 231 | 3.1 |
| Age 45 to 54 | 186 | 3.0 |
| Age 55 to 64 | 81 | 2.9 |
| Age 65 to 74 | 10 | 2.6 |
| Age 75 and up |
Ratings by Sex for EFFEXOR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 224 | 3.07589285714286 |
| Female | 687 | 3.03056768558952 |
| Not Specified | 14 | 2.71428571428571 |
Would you like to find reviews for EFFEXOR taken for a specific reason or resulting in a specific side effect?
Filter Results for EFFEXOR
FDA Drug Safety Information for EFFEXOR
Check here for Ask a Patient's Adverse Event Summary for EFFEXOR based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
EFFEXOR (VENLAFAXINE HYDROCHLORIDE): Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. FDA Approval Date: 1993-12-28 (Sources: U.S. Centers for Medicare Services, FDA)
